GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
The compounded formulation with B6 contains the same active peptide and would be expected to provide the same glucose-lowering effects
"Individualized virtual integrative medicine (IVIM): A clinical model for enhanced GLP-1 therapeutic outcomes." ScienceDirect
Regrowth generally occurs within 3-6 months as the hair follicles reactivate, responding positively to improved conditions
Is a clinical review required, and what happens if I'm not eligible
However, this approach should be balanced against the potential for nighttime nausea to disrupt sleep quality